ADA: Once-Daily Orforglipron Linked to Significant Weight Reduction

MONDAY, June 26, 2023 -- The nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron as a once-daily oral therapy is associated with clinically significant weight reduction, according to a study published online June 23 in the New...